Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaracal Gold Regulatory News (GCAT)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Caracal Gold (GCAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
GCAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction to terms of Mill End Facility

16 May 2023 16:30

RNS Number : 6223Z
Caracal Gold PLC
16 May 2023
 

16 May 2023

 

Caracal Gold plc / EPIC: GCAT / Market: Main / Sector: Mining

 

Caracal Gold plc ('Caracal' or the 'Company')

Correction to announcement regarding Settlement of Mill End Facility

Caracal Gold plc announces that further to its announcement on 12 May 2023, regarding the settlement of the Mill End Facility and PDMR Shareholding, an error in the key terms of the Mill End Financing (the "Mill End Financing").

 It was stated on 12 May 2023 that the Company would be paying US$823,258 in cash, or failing the ability to make the payment in cash by the issue of Ordinary Shares ("Ordinary Shares") in the company at the issue price of the lower of: 0.035 pence; the issue price of the Placing Shares or (if lower) of any other Ordinary Shares issued by the Company following the date of this announcement, as is equal to US$823,258.

The issue price of 0.035 pence is incorrect and should have stated the issue price as 0.35 pence.

Please see the full form corrected announcement below:

Caracal Gold plc, the East African gold explorer, developer and producer with over 1,300,000oz of JORC compliant gold resources, is pleased to announce revised terms of the existing Mill End Financing Facility (the "Mill End Financing")

Settlement of Mill End Facility

On 22 June 2022 the Company entered into a debt finance arrangement with Mill End Capital Limited ("Mill End") for the principal amount of US$1,500,000. This was intended to be a short-term financing facility, but due to delays and the withdrawal of financing facilities that had been under negotiation, the terms and amount payable under the Mill End Financing had to be renegotiated. The Company is pleased to announce that agreement has been reached with Mill End on revised financing terms. 

The total amount payable by the Company to Mill End is US$1,823,258.

The Company will repay the Mill End Financing as follows:

· Payment of US$250,000 by 17 May 2023;

 

· Further payments amounting to US$150,000 by 7 June 2023;

 

· The Company paying US$600,000 by no later than five days after Placing Shares ("Placing Shares") are admitted to trading on the London Stock Exchange Main Market pursuant to the prospectus currently being prepared by the Company being published; and

 

· The Company paying US$823,258 in cash, or failing the ability to make the payment in cash by the issue of Ordinary Shares ("Ordinary Shares") in the company at the issue price of the lower of: 0.35 pence; the issue price of the Placing Shares or (if lower) of any other Ordinary Shares issued by the Company following the date of this announcement, as is equal to US$823,258.

 

The Company is pleased with this outcome, Robbie McCrae commented:

"We are delighted that we have managed to settle this negotiation on amicable terms. We are grateful to Mill End for their understanding and support". 

Director / PDMR Shareholding

Gerard Kisbey-Green, a non-exec Director of the Company, and the sole owner of Theseus Enterprises Limited ("Theseus"), acting through Theseus transferred on 3rd February 2023, 55,300,000 Ordinary Shares of 0.1 pence in the Company ("Ordinary Shares"), representing approximately 2.94 per cent. of the issued share capital, to Mill End Capital Limited.

 

As disclosed in the prospectus dated 19 July 2021, Gerard Kisbey-Green had nominated to have his share entitlement in the Company issued in the name of Theseus Enterprises Limited. On 22 June 2022, Gerard Kisbey-Green signed a director's undertaking along with Robert McCrae, pledging Theseus 55,300,000 Ordinary Shares as part of a financing transaction between Theseus and Mill End Capital Limited. As per the terms of the agreement, the pledge has been exercised, resulting in the transfer of an aggregate of 55,300,000 Ordinary Shares to Mill End Capital Limited. 

Robert McCrae, a Director of the Company, and the sole owner of Mansa Capital Limited ("Mansa"), acting through Mansa transferred (further to the Company's announcement of 23rd January 2023) 18,929,616 Ordinary Shares of 0.1 pence each in the Company to Mr Gary McConnell and 79,570,384 Ordinary Shares of 0.1 pence each in the Company on 18 April 2023, to Mill End Capital Limited, together representing approximately 5.15 per cent. of the issued share capital.

As disclosed in the prospectus dated 19 July 2021, Mr McCrae had nominated to have his share entitlement in the Company issued in the name of Mansa Capital Limited. On 22 June 2022, Mr McCrae signed a director's undertaking along with Mr Kisbey-Green, pledging Mansa's 98,500,000 Ordinary Shares as part of a financing transaction between Caracal and Mill End Capital Limited. As per the terms of the agreement, the pledge has been exercised, resulting in the transfer of the 96,779,126 Ordinary Shares to Mill End Capital Limited.

Following the transfer, neither Mr Kisbey-Green nor Mr McCrae hold any direct interest in the Company.

The transfer of the Ordinary Shares was made in accordance with the terms of the Directors undertaking and does not result in any change to the Company's issued share capital.

 

For further information visit www.caracalgold.com or contact the following:

Caracal Gold plc

Robbie McCrae

robbie@kilimapesa.com

VSA Capital Limited

Financial Adviser and Joint Broker

Andrew Raca (Corporate Finance)

 

+44 203 005 5000

DGWA, the German Institute for Asset and

Equity Allocation and Valuation

European Investor and Corporate Relations Advisor

Katharina Löckinger

info@dgwa.org

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMKKVLGFZM
Date   Source Headline
26th Mar 20249:08 amRNSSubscription to raise £780,000
7th Mar 202410:31 amRNSUpdate
23rd Jan 20249:30 amRNSSubscription to raise £140,000
19th Jan 20245:46 pmRNSFinancing Update
14th Nov 20237:00 amRNS$1.55m Debt Funding Update
1st Nov 20237:00 amRNSDelay to Publication of Annual Report and Accounts
26th Oct 20237:00 amRNSMine Plan for Kilimapesa expansion
24th Oct 20233:48 pmRNSDelay to Publication of Annual Report and Accounts
9th Oct 20238:32 amRNSResults of General Meeting
29th Sep 202311:16 amRNSSubscription raises £92,750
11th Sep 20237:00 amRNSNotice of General Meeting
4th Aug 20237:00 amRNSCorporate Update and Q2 2023
19th Jul 20239:29 amRNSResignation of Non-Executive Director
13th Jul 20233:55 pmRNSFinancing and group reserves and resources update
22nd Jun 202312:22 pmRNSTanzania Completion Update
12th Jun 20234:06 pmRNSCorporate Governance and Board Changes Update
7th Jun 202310:14 amRNSTR-1: Notification of Major Holdings
16th May 20234:30 pmRNSCorrection to terms of Mill End Facility
16th May 202310:51 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSCorporate Update and Q1 2023 Operations Summary
12th May 20233:24 pmRNSSettlement of Loan Facility and PDMR Shareholding
26th Apr 20237:00 amRNSChairman Confirmation & Governance Review Update
24th Apr 20239:20 amRNSStatement re. Mining and Ore Processing Results
31st Mar 20232:32 pmRNSInterim results 31 December 2022
30th Mar 20237:00 amRNSHigh Grade Zone on Kilimapesa Hill
21st Mar 20239:05 amRNSSecond Price Monitoring Extn
21st Mar 20239:00 amRNSPrice Monitoring Extension
21st Mar 20237:00 amRNSHigh Grade Zone on Kilimapesa Hill
7th Mar 202310:37 amRNSTR-1: Notification
20th Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20234:40 pmRNSSecond Price Monitoring Extn
16th Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSAdditional Financing Secured & Corporate Update
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
24th Jan 20232:00 pmRNSPrice Monitoring Extension
24th Jan 20239:05 amRNSSecond Price Monitoring Extn
24th Jan 20239:00 amRNSPrice Monitoring Extension
23rd Jan 20234:45 pmRNSCorporate Update, Q3 &Q4 2022 Operations Summary
23rd Jan 202311:43 amRNSResult of AGM
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 20234:30 pmRNSBoard Change
10th Jan 20239:05 amRNSSecond Price Monitoring Extn
10th Jan 20239:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSFinancing Update
21st Dec 20229:00 amRNSPrice Monitoring Extension
21st Dec 20227:00 amRNSScoping Study Delivers Robust Project Economics
13th Dec 20222:05 pmRNSSecond Price Monitoring Extn
13th Dec 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.